Cited by 764Cancer-related molecular mechanisms researchRNA Research and SplicingMicroRNA in disease regulation

Non-coding RNAs as regulators of gene expression and epigenetics

Open access
Kaikkonen, M. U., Lam, M. T. Y., Glass, C. K.·2011·Cardiovascular Research

Abstract

Genome-wide studies have revealed that mammalian genomes are pervasively transcribed. This has led to the identification and isolation of novel classes of non-coding RNAs (ncRNAs) that influence gene expression by a variety of mechanisms. Here we review the characteristics and functions of regulatory ncRNAs in chromatin remodelling and at multiple levels of transcriptional and post-transcriptional regulation. We also describe the potential roles of ncRNAs in vascular biology and in mediating epigenetic modifications that might play roles in cardiovascular disease susceptibility. The emerging recognition of the diverse functions of ncRNAs in regulation of gene expression suggests that they may represent new targets for therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvr097

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Noncoding small RNAs (e.g., miRNAs) are able to mediate sequence-specific modulation of gene expression by different mechanisms.

    “Lastly, noncoding small RNAs (e.g., miRNAs) are also able to mediate sequence-specific modulation of gene expression by different mechanisms (56).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K.
Affiliations
  • University of Eastern Finland (FI)
  • University of California San Diego (US)
Venue
Cardiovascular Research
Published
2011-05-09
Volume
90
Issue
3
Pages
430-440
ISSN
0008-6363 (ISSN-L)
OpenAlex
W2010691380
Cited by
764
References
147
Citations by year
2026: 52 · 2025: 107 · 2024: 86 · 2023: 55 · 2022: 43 · 2021: 54 · 2020: 55 · 2019: 45 · 2018: 44 · 2017: 43 · 2016: 36 · 2015: 48 · 2014: 30 · 2013: 31 · 2012: 29
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Foundation for Cardiovascular Research
  • Fondation Leducq
  • Suomen Kulttuurirahasto
  • Sydäntutkimussäätiö
  • Orionin Tutkimussäätiö
  • National Institutes of Health
  • University of California, San Diego (T32 GM008666)
  • National Institute of General Medical Sciences (GM008666, GM-007198, T32GM008666, T32GM007198)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
non-coding RNA, gene expression regulation, epigenetics, chromatin remodeling, transcriptional regulation, post-transcriptional regulation, pervasive transcription, vascular biology, cardiovascular disease susceptibility, therapeutic target
MeSH terms
Animals, Cardiovascular Diseases, Enhancer Elements, Genetic, Gene Expression Regulation, Humans, Models, Genetic, Promoter Regions, Genetic, RNA Processing, Post-Transcriptional, Genetic Predisposition to Disease, RNA, Untranslated, RNA, Small Interfering, MicroRNAs, Chromatin Assembly and Disassembly, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review